Protara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	12.55	162.8	39.59	24.13	35.72	168.6
Short-Term Investments	120.12	7.49	25.99	60.24	55.51	-
Cash & Short-Term Investments	132.67	170.29	65.58	84.37	91.23	168.6
Cash Growth	62.79%	159.67%	-22.27%	-7.52%	-45.89%	29793.26%
Other Receivables	1	-	0.24	0.49	0.63	-
Receivables	1	-	0.24	0.49	0.63	-
Prepaid Expenses	0.48	0.93	0.89	0.59	0.53	0.53
Restricted Cash	-	-	-	-	-	0.05
Other Current Assets	1.49	0.94	1.99	0.7	0.72	0.26
Total Current Assets	135.64	172.16	68.71	86.15	93.11	169.44
Property, Plant & Equipment	4.28	5.28	6.56	7.87	8.89	2.3
Long-Term Investments	0.96	-	-	17.89	39.47	-
Goodwill	-	-	-	-	29.52	29.52
Long-Term Deferred Charges	2.99	3.25	2.66	0.08	-	-
Other Long-Term Assets	0.77	0.77	1.03	1.31	1.61	1.91
Total Assets	144.64	181.45	78.95	113.29	172.6	203.16
Accounts Payable	4.5	4.43	2.43	1.59	0.95	0.91
Accrued Expenses	4.18	5.41	2.73	3.24	2.49	1.75
Current Portion of Leases	1.22	1.12	0.98	0.92	0.86	0.09
Current Income Taxes Payable	-	-	-	-	-	0.16
Total Current Liabilities	9.91	10.96	6.15	5.74	4.3	2.92
Long-Term Leases	2.44	3.36	4.48	5.47	6.38	1
Total Liabilities	12.35	14.32	10.63	11.21	10.68	3.91
Common Stock	0.04	0.04	0.01	0.01	0.01	0.01
Additional Paid-In Capital	417.22	412.08	268.73	262.72	256.13	245.99
Retained Earnings	-285.11	-244.98	-200.38	-159.96	-94.01	-46.76
Comprehensive Income & Other	0.14	0	-0.03	-0.69	-0.21	-
Shareholders' Equity	132.29	167.13	68.32	102.08	161.91	199.24
Total Liabilities & Equity	144.64	181.45	78.95	113.29	172.6	203.16
Total Debt	3.66	4.48	5.47	6.38	7.24	1.09
Net Cash (Debt)	129.97	165.81	60.11	95.87	123.46	167.51
Net Cash Growth	69.31%	175.83%	-37.30%	-22.34%	-26.30%	29600.53%
Net Cash Per Share	3.41	8.05	5.31	8.51	10.99	23.16
Filing Date Shares Outstanding	38.59	36.77	11.43	11.31	11.25	11.23
Total Common Shares Outstanding	38.59	35.04	11.36	11.27	11.24	11.21
Working Capital	125.74	161.19	62.56	80.41	88.81	166.52
Book Value Per Share	3.43	4.77	6.01	9.06	14.41	17.77
Tangible Book Value	132.29	167.13	68.32	102.08	132.4	169.73
Tangible Book Value Per Share	3.43	4.77	6.01	9.06	11.78	15.14
Machinery	-	1.5	1.51	1.42	1.12	0.66
Leasehold Improvements	-	0.55	0.55	0.55	0.22	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.